Comparison of the Efficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache

What this Trial Is About

Cervicogenic headache (CBH) is a type of headache caused by problems in the cervical spine, including bones, discs, or soft tissues, often accompanied by neck pain. This research aims to compare the effects of two therapy methods, Mulligan mobilization and myofascial release, in treating cervicogenic headache through a prospective clinical study involving adults aged 18 to 65 years with symptoms lasting at least three months. The study follows ethical principles and collects detailed patient information including medical history and sociodemographic data. Participants will be randomly assigned to one of three groups. Group one will receive Mulligan mobilization therapy three times weekly for four weeks (12 sessions total) along with a home exercise program. Group two will receive myofascial release therapy on the same schedule plus the home exercises. Group three will follow only the home exercise program, also three times weekly for four weeks. Each therapy session involves specific manual techniques administered by a therapist, and the home exercises focus on neck mobility and strengthening. Throughout the study, patients will be evaluated before treatment, immediately after, and one month after completing therapy. Assessments include headache frequency recorded in a diary, pain intensity using a visual analog scale, and functional status via the headache impact test. Headache-related disability and quality of life will also be measured using standardized questionnaires. Weekly phone calls will support exercise adherence, and the study monitors outcomes to assess therapy effectiveness and patient quality of life over time.

Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache